Skip to main content
SEER
NASDAQ Industrial Applications And Services

Seer Board Urges Shareholders to Vote 'FOR' Nominees Amidst Activist Proxy Battle

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.71
Mkt Cap
$94.59M
52W Low
$1.65
52W High
$2.41
52W Position info
3.6% above low
Off High info
29% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

SEER is trading near its 52-week low of $1.65 (3.6% above the low) on light trading volume (0.3× avg).

Summary

Seer, Inc. is actively soliciting shareholder votes for its current board nominees ahead of the July 28, 2026 Annual Meeting, defending against an activist investor group seeking to replace directors and acquire the company.


Key Events · Corporate Governance and Compliance · SEER

  • Proxy Contest Intensifies

    Seer is actively soliciting votes for its current board nominees ahead of the July 28, 2026 Annual Meeting, urging shareholders to use the BLUE proxy card.

  • Rejection of Acquisition Bids

    The board reiterates its unanimous rejection of activist acquisition proposals from Bradley Radoff and Michael Torok, stating they are priced below the value of cash, cash equivalents, and investments on the balance sheet.

  • Defense of Current Strategy

    The company highlights its strategy to pioneer the proteomics market, citing scientific validation, accelerating commercial momentum, disciplined financial management, and a robust innovation pipeline.

  • Board Nominees Defended

    Seer specifically defends three directors (Omid Farokhzad, Terrance McGuire, Dipchand Nishar) targeted for replacement by the activist group, emphasizing their qualifications and long-term commitment.


Analysis · SEER · Industrial Applications And Services

This filing is a critical communication in an ongoing, high-stakes proxy contest for control of Seer, Inc. The board is actively soliciting shareholder votes to retain its current nominees and strategy, rejecting activist acquisition proposals that were priced at a premium to the current stock price. The outcome of the Annual Meeting on July 28, 2026, will determine the company's strategic direction, either continuing its long-term proteomics development or potentially being sold. The company is defending its position while its stock trades near 52-week lows, which could be viewed negatively by shareholders seeking an immediate premium exit.

At the time of this filing, SEER was trading at $1.71 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $94.6M. The 52-week trading range was $1.65 to $2.41. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SEER - Latest Insights

SEER
Jul 30, 2026, 6:52 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.18
Real-time Price: $2.19 info
Change: +$0.0100 (+0.46%) info
Market Cap: $113.951M info
SEER
Jul 30, 2026, 5:30 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $2.19 info
Change: -$0.010 (-0.45%) info
Market Cap: $113.951M info
SEER
Jul 28, 2026, 12:54 PM EDT
Filing Type: DFAN14A
Importance Score:
9
Price at Filing: $2.02
Real-time Price: $2.19 info
Change: +$0.175 (+9%) info
Market Cap: $113.951M info
SEER
Jul 28, 2026, 12:47 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.03
Real-time Price: $2.19 info
Change: +$0.165 (+8%) info
Market Cap: $113.951M info
SEER
Jul 23, 2026, 6:25 PM EDT
Filing Type: DFAN14A
Importance Score:
9
Price at Filing: $2.04
Real-time Price: $2.19 info
Change: +$0.150 (+7%) info
Market Cap: $113.951M info